These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20238050)

  • 1. Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency.
    Fliesler SJ
    Adv Exp Med Biol; 2010; 664():481-9. PubMed ID: 20238050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ
    Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
    Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
    Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
    Fliesler SJ; Xu L
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome.
    Fliesler SJ; Peachey NS; Herron J; Hines KM; Weinstock NI; Ramachandra Rao S; Xu L
    Sci Rep; 2018 Jan; 8(1):1286. PubMed ID: 29352199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome.
    Richards MJ; Nagel BA; Fliesler SJ
    Exp Eye Res; 2006 Mar; 82(3):538-41. PubMed ID: 16199034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species.
    Ford DA; Monda JK; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
    J Neurochem; 2008 May; 105(3):1032-47. PubMed ID: 18182048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Xu L; Sheflin LG; Porter NA; Fliesler SJ
    Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
    Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
    Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights into the Smith-Lemli-Opitz syndrome.
    Yu H; Patel SB
    Clin Genet; 2005 Nov; 68(5):383-91. PubMed ID: 16207203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
    Kolf-Clauw M; Chevy F; Ponsart C
    J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome.
    Pfeffer BA; Xu L; Fliesler SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.
    Correa-Cerro LS; Porter FD
    Mol Genet Metab; 2005 Feb; 84(2):112-26. PubMed ID: 15670717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome.
    Fliesler SJ; Vaughan DK; Jenewein EC; Richards MJ; Nagel BA; Peachey NS
    Pediatr Res; 2007 Mar; 61(3):273-8. PubMed ID: 17314682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
    Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome.
    Tu C; Li J; Jiang X; Sheflin LG; Pfeffer BA; Behringer M; Fliesler SJ; Qu J
    Mol Cell Proteomics; 2013 Dec; 12(12):3583-98. PubMed ID: 23979708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
    Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
    Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
    Battaile KP; Steiner RD
    Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis.
    Porter FD
    Mol Genet Metab; 2000; 71(1-2):163-74. PubMed ID: 11001807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy.
    Correa-Cerro LS; Wassif CA; Kratz L; Miller GF; Munasinghe JP; Grinberg A; Fliesler SJ; Porter FD
    Hum Mol Genet; 2006 Mar; 15(6):839-51. PubMed ID: 16446309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.